KioMedineVSOne

KioMedineVSOne
Product Description

KioMedine(vs)one is a unique soft implant for OsteoArthritis pain relief and outstanding response rate
KioMedine(vs)one is the new generation single-shot injection intended for the symptomatic treatment of knee osteoarthritis based on world-first exclusive animal-free KiOmedine® CM Chitosan.

  • Treatment response up to 76%
  • 86% of patient satisfied
  • 90% of physicians satisfied
KiOmedine® CM Chitosan is a patented technology made in Belgium, resulting from years of research and innovation. Thanks to a unique structure that differs from hyaluronic acid and natural chitosanKioMedine(vs)one has an exclusive dual mechanism of action : improves lubrication and protect the endogenous synovial components thanks to its unprecedented free radical scavenging capacity. 

KiOmed Pharma

  • BE
  • 2020
    On CPHI since
Specifications
  • CAS Registry Number
    05404023514004
  • Supplied from
    Belgium

KiOmed Pharma

  • BE
  • 2020
    On CPHI since

KiOmed Pharma resources (1)